Epidermal signal transduction and transcription factor activation in activated keratinocytes

Journal of Dermatological Science

Volumn 17, Issue 3, 1998, Pages 167-181

  Tomic Canic, Marjana ^a   Komine, Mayumi ^a,c   Freedberg, Irwin M ^a   Blumenberg, Miroslav ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Epidermal signal transduction; Keratinocyte; Transcription factor activation

Indexed keywords

EPIDERMAL GROWTH FACTOR; INTERFERON; INTERLEUKIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

EPIDERMIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; KERATINS; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGY; TRANSCRIPTION FACTORS;

EID: 0032126281     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00016-4     Document Type: Review

References (96)

1. Eckert R.L. Structure, function, and differentiation of the keratinocyte (Review). Physiol Rev. 69:1989;1316-1346.
2. Fuchs E. Epidermal differentiation: The bare essentials. J Cell Biol. 111:1990;2807-2814.
3. Blumenberg M. Keratinocytes: Biology and Differentiation. Cutaneous Medicine and Surgery. Philadelphia, PA: W.B. Saunders, 1994;1:58-74.
4. Nelson W.G., Sun T.-T. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J Cell Biol. 97:1983;244-251.
5. Fuchs E., Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 19:1980;1033-1042.
6. Roop D.R., Krieg T.M.et al. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res. 48:1988;3245-3252.
7. Simon M., Green H. Participation of membrane-associated proteins in the formation of the cross-linked envelope of the keratinocyte. Cell. 36:1984;827-834.
8. Dale B.A., Holbrook K.A.et al. Expression of epidermal keratins and filaggrin during human fetal skin development. J Cell Biol. 101:1985;1257-1269.
9. Hohl D., Lichti U.et al. Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol. 96:1991;414-418.
10. Kupper T.S. Immune and inflammatory processes in cutaneous tissues. Mech Inflammation Cutaneous Tissues. 86:1990;1783-1789.
11. Ansel J., Perry P.et al. Cytokine modulation of keratinocyte cytokines (Review). J Invest Dermatol. 94:1990;101S-107S.
12. Komine M., Freedberg I.M.et al. Regulation of epidermal expression of keratin K17 in inflammatory skin diseases. J Invest Dermatol. 107:1996;569-575.
13. Nickoloff B.J., Turka L.A. Keratinocytes: key immunocytes of the integument (Review). Am J Pathol. 143:1993;325-331.
14. Weiss RA, Eichner R et al. Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48- and 56-kDalton keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984;98.
15. Jiang C.K., Magnaldo T.et al. Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc Natl Acad Sci USA. 90:1993;6786-6790.
16. Jiang C.K., Flanagan S.et al. Disease-activated transcription factor: allergic reactions in human skin cause nuclear transcription of STAT-91 and induce synthesis of keratin K17. Mol Cell Biol. 14:1994;4759-4769.
17. Coffey R.J. Jr., Derynck R.et al. Production and auto-induction of transforming growth factor-α in human keratinocytes. Nature. 328:1987;817-820.
18. Kupper TS. Role of epidermal cytokines. In: Oppenheim JJ, Shevach EM, editors. Immunophysiology. The Role of Cells and Cytokines in Immunity and Inflammation. London - New York: Oxford University Press, 1990;285-305.
19. Nickoloff B.J., Griffiths C.E.et al. The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease-1990 update (Review). J Invest Dermatol. 94:1990;151S-157S.
20. Marinkovich M.P., Lunstrum G.P.et al. The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol. 119:1992;695-703.
21. Alitalo K., Kuismanen E.et al. Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells. J Cell Biol. 94:1982;497-505.
22. O'Keefe E.J., Woodley D.T.et al. Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol. 88:1987;634-639.
23. Burgeson R.E. Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol. 101:1993;252-255.
24. Schindler C., Darnell J. Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway (Review; 145 Refs.). Annu Rev Biochem. 64:1995;621-651.
25. Eron L.J., Toy C.et al. Therapy of genital herpes with topically applied interferon. Antimicrob Agents Chemother. 31:1987;1137-1139.
26. Gearing D.P., Comeau M.R.et al. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 255:1992;1434-1437.
27. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity (Review). Cell. 61:1990;203-212.
28. Davis R.J. The mitogen-activated protein kinase signal transduction pathway (Review; 55 Refs.). J Biol Chem. 268:1993;14553-14556.
29. Nanney L.B., Stoscheck C.M.et al. Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol. 94:1990;742-748.
30. Nickoloff B.J., Mitra R.S.et al. Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol. 132:1988;543-551.
31. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity (Review; 129 Refs.). Cell. 80:1995;199-211.
32. Derijard B., Hibi M.et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
33. Gupta S., Campbell D.et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
34. Gupta S., Barrett T.et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
35. Rosette C., Karin M. Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol. 128:1995;1111-1119.
36. Galcheva-Gargova Z., Derijard B.et al. An osmosensing signal transduction pathway in mammalian cells. Science. 265:1994;806-808.
37. Kolde G., Schulze-Osthoff K.et al. Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Dermatol Res. 284:1992;154-158.
38. Kock A., Schwarz T.et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 172:1990;1609-1614.
39. Nickoloff B.J., Karabin G.D.et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol. 138:1991;129-140.
40. Barker J.N.W.N., Mitra R.S.et al. Keratinocytes as initiators of inflammation. Lancet. 337:1991;211-214.
41. Griffiths T.W., Griffiths C.E.et al. Immunopathogenesis and immunotherapy of psoriasis (Review; 159 Refs.). Dermatol Clin. 13:1995;739-749.
42. Rothe M., Wong S.C.et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
43. Rothe M., Pan M.G.et al. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
44. Malinin N.L., Boldin M.P.et al. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature. 385:1997;540-544.
45. Natoli G., Costanzo A.et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science. 275:1997;200-203.
46. Shu H.B., Takeuchi M.et al. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA. 93:1996;13973-13978.
47. Levy D., Darnell J.E. Jr. Interferon-dependent transcriptional activation: signal transduction without second messenger involvement? New Biol. 2:1990;923-928.
48. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation (Review; 276 Refs.). Biochim Biophys Acta. 1072:1991;129-157.
49. Klampfer L., Lee T.H.et al. NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1. Mol Cell Biol. 14:1994;6561-6569.
50. Basset-Seguin N., Demoly P.et al. Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation. Oncogene. 9:1994;765-771.
51. Bernerd F., Magnaldo T.et al. Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins. Gene Exp. 3:1993;187-199.
52. Saez E., Rutberg S.E.et al. c-fos is required for malignant progression of skin tumors. Cell. 82:1995;721-732.
53. Rutberg S.E., Saez E.et al. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene. 13:1996;167-176.
54. Fisher C., Byers M.R.et al. Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development. 111:1991;253-258.
55. Welter J.F., Crish J.F.et al. Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem. 270:1995;12614-12622.
56. Lu B., Rothnagel J.A.et al. Differentiation-specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element. J Biol Chem. 269:1994;7443-7449.
57. Lohman F.P., Medema J.K.et al. Expression of the SPRR cornification genes is differentially affected by carcinogenic transformation. Exp Cell Res. 231:1997;141-148.
58. Presland R.B., Haydock P.V.et al. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem. 267:1992;23772-23781.
59. Pankov R., Neznanov N.et al. AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol. 14:1994;7744-7757.
60. Oshima R.G., Abrams L.et al. Activation of an intron enhancer within the keratin 18 gene by expression of c-fos and c-jun in undifferentiated F9 embryonal carcinoma cells. Genes Dev. 4:1990;835-848.
61. Miyamoto S., Verma I.M. Rel/NF-kappa B/I kappa B story (Review; 236 Refs.). Adv Cancer Res. 66:1995;255-292.
62. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases (Review; 53 Refs.). New Engl J Med. 336:1997;1066-1071.
63. Beg A.A., Finco T.S.et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol. 13:1993;3301-3310.
64. Matsusaka T., Fujikawa K.et al. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci USA. 90:1993;10193-10197.
65. Stein B., Baldwin A. Jr.et al. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
66. Trautwein C., Caelles C.et al. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature. 364:1993;544-547.
67. Tseng H., Green H. Association of basonuclin with ability of keratinocytes to multiply and with absence of terminal differentiation. J Cell Biol. 126:1994;495-506.
68. Wegner M., Drolet D.W.et al. POU-domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol. 5:1993;488-498.
69. Magnaldo T., Vidal R.G.et al. On the role of AP2 in epithelial-specific gene expression. Gene Exp. 3:1993;307-315.
70. Ohtsuki M., Flanagan S.et al. A cluster of five nuclear proteins regulates keratin transcription. Gene Exp. 3:1993;201-213.
71. Blumenberg M. Molecular biology of human keratin genes. In: Darmon M, Blumenberg M, editors. Molecular Biology of the Skin: The Keratinocyte. New York: Academic Press, 1993:1-24.
72. Kadonaga J.T., Tjian R. Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci USA. 83:1986;5889-5893.
73. Majello B., De Luca P.et al. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:1994;4914-4921.
74. Mastrangelo I.A., Courey A.J.et al. DNA looping and Sp1 multimer links: A mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci USA. 88:1991;5670-5674.
75. Pascal E., Tijan R. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1991;1646-1656.
76. Li S., Rosen J.M. Nuclear factor I and mammary gland factor (STAT5) play a critical role in regulating rat whey acidic protein gene expression in transgenic mice. Mol Cell Biol. 15:1995;2063-2070.
77. Roop D.R., Huitfeldt H.et al. Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation. 35:1987;143-150.
78. Blessing M., Zentgraf H.et al. Differentially expressed bovine cytokeratin genes. Analysis of gene linkage and evolutionary conservation of 5′-upstream sequences. EMBO J. 6:1987;567-575.
79. Blumenberg M., Tomic-Canic M. Human epidermal keratinocyte: keratinization processes (Review; 99 Refs.). Exs. 78:1997;1-29.
80. Leask A., Byrne C.et al. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc Natl Acad Sci USA. 88:1991;7948-7952.
81. Magnaldo T., Bernerd F.et al. Transcriptional regulators of expression of K#16, the disease-associated keratin. DNA Cell Biol. 12:1993;911-923.
82. Wu R.L., Galvin S.et al. A 300 bp 5′-upstream sequence of a differentiation-dependent rabbit K3 keratin gene can serve as a keratinocyte-specific promoter. J Cell Sci. 105:1993;303-316.
83. de Jong E.M., van Vlijmen I.M.et al. Keratin 17: a useful marker in anti-psoriatic therapies. Arch Dermatol Res. 283:1991;480-482.
84. Blumenberg M. The molecular link between the immune system and the epidermis: disease-activated transcription factor in human skin. Chron Dermatol. 4:1994;193-205.
85. Guelstein V.I., Tchypysheva T.A.et al. Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer. 42:1988;147-153.
86. Wetzels R.H.W., Kuijpers H.J.et al. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol. 138:1991;751-763.
87. Moll R., Moll I.et al. Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res. 276:1984;349-363.
88. Troyanovsky S.M., Leube R.E.et al. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol. 59:1992;127-137.
89. Kaplan G., Witmer M.D.et al. Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci USA. 83:1986;3469-3473.
90. Heid H.W., Moll I.et al. Patterns of expression of trichocytic and epithelial cytokeratins in mammalian tissues. I. Human and bovine hair follicles. Differentiation. 37:1988;137-157.
91. Rentrop M., Knapp B.et al. Differential localization of distinct keratin mRNA-species in mouse tongue epithelium by in situ hybridization with specific cDNA probes. J Cell Biol. 103:1986;2583-2591.
92. Smith G.H., Mehrel T.et al. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ. 1:1990;161-170.
93. Schweizer J., Kinjo M.et al. Sequential expression of mRNA-encoded keratin sets in neonatal mouse epidermis: basal cells with properties of terminally differentiating cells. Cell. 37:1984;159-170.
94. Schermer A., Jester J.V.et al. Transient synthesis of K6 and K16 keratins in regenerating rabbit corneal epithelium: keratin markers for an alternative pathway of keratinocyte differentiation. Differentiation. 42:1989;103-110.
95. Choi Y., Fuchs E. TGF-B and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul. 1:1990;791-809.
96. Rosenthal D.S., Griffiths C.E.et al. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol. 98:1992;343-350.